|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/713 | |
| C12N 15/113 |
| (11) | Patento numeris | 2723756 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12802870.1 |
| Europos patento paraiškos padavimo data | 2012-06-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-04-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/043642 |
| Data | 2012-06-21 |
| (87) | Numeris | WO 2012/177947 |
| Data | 2012-12-27 |
| (30) | Numeris | Data | Šalis |
| 201161499620 P | 2011-06-21 | US |
| (72) |
BETTENCOURT, Brian, US
FITZGERALD, Kevin, US
MILSTEIN, Stuart, US
MAIER, Martin, US
CHARISSE, Klaus, US
RAJEEV, Kallanthottathil, US
KUCHIMANCHI, Satya, US
MANOHARAN, Muthiah, US
NGUYEN, Tuyen, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
|
| (54) | COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES |
| COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES |